pubmed-article:9587957 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:9587957 | lifeskim:mentions | umls-concept:C0026549 | lld:lifeskim |
pubmed-article:9587957 | lifeskim:mentions | umls-concept:C0034721 | lld:lifeskim |
pubmed-article:9587957 | lifeskim:mentions | umls-concept:C0034693 | lld:lifeskim |
pubmed-article:9587957 | lifeskim:mentions | umls-concept:C0031327 | lld:lifeskim |
pubmed-article:9587957 | lifeskim:mentions | umls-concept:C0242643 | lld:lifeskim |
pubmed-article:9587957 | lifeskim:mentions | umls-concept:C0851347 | lld:lifeskim |
pubmed-article:9587957 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
pubmed-article:9587957 | lifeskim:mentions | umls-concept:C1999216 | lld:lifeskim |
pubmed-article:9587957 | lifeskim:mentions | umls-concept:C0527835 | lld:lifeskim |
pubmed-article:9587957 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:9587957 | pubmed:dateCreated | 1998-7-23 | lld:pubmed |
pubmed-article:9587957 | pubmed:abstractText | The objective of this study was to evaluate the effect of a potent P-gp inhibitor, GF120918, on the systemic pharmacokinetics and antinociceptive pharmacodynamics of a single intravenous dose of morphine in rats. | lld:pubmed |
pubmed-article:9587957 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9587957 | pubmed:language | eng | lld:pubmed |
pubmed-article:9587957 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9587957 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:9587957 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9587957 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9587957 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9587957 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9587957 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9587957 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9587957 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9587957 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9587957 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9587957 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:9587957 | pubmed:month | Apr | lld:pubmed |
pubmed-article:9587957 | pubmed:issn | 0724-8741 | lld:pubmed |
pubmed-article:9587957 | pubmed:author | pubmed-author:BrouwerK LKL | lld:pubmed |
pubmed-article:9587957 | pubmed:author | pubmed-author:PollackG MGM | lld:pubmed |
pubmed-article:9587957 | pubmed:author | pubmed-author:BrouwerK RKR | lld:pubmed |
pubmed-article:9587957 | pubmed:author | pubmed-author:LetrentS PSP | lld:pubmed |
pubmed-article:9587957 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:9587957 | pubmed:volume | 15 | lld:pubmed |
pubmed-article:9587957 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:9587957 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:9587957 | pubmed:pagination | 599-605 | lld:pubmed |
pubmed-article:9587957 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
pubmed-article:9587957 | pubmed:meshHeading | pubmed-meshheading:9587957-... | lld:pubmed |
pubmed-article:9587957 | pubmed:meshHeading | pubmed-meshheading:9587957-... | lld:pubmed |
pubmed-article:9587957 | pubmed:meshHeading | pubmed-meshheading:9587957-... | lld:pubmed |
pubmed-article:9587957 | pubmed:meshHeading | pubmed-meshheading:9587957-... | lld:pubmed |
pubmed-article:9587957 | pubmed:meshHeading | pubmed-meshheading:9587957-... | lld:pubmed |
pubmed-article:9587957 | pubmed:meshHeading | pubmed-meshheading:9587957-... | lld:pubmed |
pubmed-article:9587957 | pubmed:meshHeading | pubmed-meshheading:9587957-... | lld:pubmed |
pubmed-article:9587957 | pubmed:meshHeading | pubmed-meshheading:9587957-... | lld:pubmed |
pubmed-article:9587957 | pubmed:meshHeading | pubmed-meshheading:9587957-... | lld:pubmed |
pubmed-article:9587957 | pubmed:meshHeading | pubmed-meshheading:9587957-... | lld:pubmed |
pubmed-article:9587957 | pubmed:meshHeading | pubmed-meshheading:9587957-... | lld:pubmed |
pubmed-article:9587957 | pubmed:meshHeading | pubmed-meshheading:9587957-... | lld:pubmed |
pubmed-article:9587957 | pubmed:meshHeading | pubmed-meshheading:9587957-... | lld:pubmed |
pubmed-article:9587957 | pubmed:meshHeading | pubmed-meshheading:9587957-... | lld:pubmed |
pubmed-article:9587957 | pubmed:meshHeading | pubmed-meshheading:9587957-... | lld:pubmed |
pubmed-article:9587957 | pubmed:meshHeading | pubmed-meshheading:9587957-... | lld:pubmed |
pubmed-article:9587957 | pubmed:year | 1998 | lld:pubmed |
pubmed-article:9587957 | pubmed:articleTitle | Effect of GF120918, a potent P-glycoprotein inhibitor, on morphine pharmacokinetics and pharmacodynamics in the rat. | lld:pubmed |
pubmed-article:9587957 | pubmed:affiliation | School of Pharmacy, Division of Pharmaceutics, University of North Carolina at Chapel Hill 27599, USA. | lld:pubmed |
pubmed-article:9587957 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:9587957 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:9587957 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
pubmed-article:9587957 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9587957 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9587957 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9587957 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9587957 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9587957 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9587957 | lld:pubmed |